Structure and Dynamics of a Site-Specific Labeled Fc Fragment with Altered Effector Functions
Antibody-drug conjugates (ADCs) are a class of biotherapeutic drugs designed as targeted therapies for the treatment of cancer. Among the challenges in generating an effective ADC is the choice of an effective conjugation site on the IgG. One common method to prepare site-specific ADCs is to enginee...
Main Authors: | D. Travis Gallagher, Chris McCullough, Robert G. Brinson, Joomi Ahn, John P. Marino, Nazzareno Dimasi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/10/546 |
Similar Items
-
Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
by: Andréa Cottignies-Calamarte, et al.
Published: (2023-02-01) -
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
by: Elisabeth A. van Erp, et al.
Published: (2019-03-01) -
Editorial: Antibody Fc Engineering: Towards Better Therapeutics
by: Cheng Lei, et al.
Published: (2018-10-01) -
Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
by: Rena Liu, et al.
Published: (2020-11-01) -
IgG Fc engineering to modulate antibody effector functions
by: Xinhua Wang, et al.
Published: (2017-10-01)